Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,287 results that match your search.22,287 results
  • Alice Turinas and Bart Showalter compare data protection regulations in the US and Europe and reveal some of the pitfalls that await companies doing business internationally
  • Singapore's patent rules have been amended this year to recognize search and examination reports and patents issued by the Japanese Patent Office (JPO) in the grant process of Singapore patents. Singapore patent applications with a priority filing date on or after August 15 2002, may rely on JPO search and examination reports and granted patents in place of local search and examination.
  • An action to revoke its patent on the drug Videx EC threatens to limit further Bristol-Myers Squibb's (BMS) rights to sell Aids medicines in Thailand. Three Aids patients and the Foundation for Consumers, a local group, claim that the US pharmaceutical company did not invent the drug and so should not be allowed to own the rights to it in Thailand. According to the plaintiffs, the drug is a product of collaboration between BMS and the US National Institutes of Health (NIH).
  • Vacuum cleaner maker Dyson has pocketed over £4 million ($6.24 million) in a settlement with rival Hoover. The settlement - £4 million plus costs and interest - comes just weeks before the High Court was due to decide what level of damages should be awarded against Hoover.
  • One might have thought that the question of the exhaustion of trade marks in the European Economic Area (EEA) had been resolved, or at least stabilized, to a certain extent.
  • A new law and the strict implementation of a plan to speed up litigation have seen Indonesia move closer towards international standards of trade mark protection and enforcement, claim Adolf Panggabean and Erna L Kusoy
  • In July 2000, the Korean Supreme Court handed down its first decision specifically stating the requirements for the doctrine of equivalents. Afterwards, many other relevant precedent cases have also been decided in a rather short period of time.
  • Licensing can generate millions of dollars for technology companies, but many executives still do not take full advantage of the opportunities available. Dan McCurdy and Marshall Phelps explode the myths that prevent companies from developing successful licensing programmes
  • Pharma company AstraZeneca has stopped three generics from launching rival versions of its multi-billion dollar drug Prilosec in the US. But a fourth generic company is free to manufacture its own version of the drug.